Skip to main content
. 2020 May 8;15(5):e0232343. doi: 10.1371/journal.pone.0232343

Table 5. Overall and country specific prevalence and 95% confidence intervals for phenotypic interpretation of observed mutations in smears with interpretable results for all gene targets, by case treatment status.

Case Treatment Status by Country No Drug Resistance Mono-Resistance Multi-Drug Resistance Poly-Resistance Any Drug Resistant Smears
Prevalence (%) 95% CI Prevalence (%) 95% CI Prevalence (%) 95% CI Prevalence (%) 95% CI Prevalence (%) 95% CI
Ghana
New 111/125 (88.80) 81.92, 93.74 13/125 (10.40) 5.65, 17.13 1/125 (0.80) 0.02, 4.38 0/125 (0.00) 0.00, 2.91 14/125 (11.20) 6.26, 18.08
Unknown 115/139 (82.73) 75.41, 85.61 11/139 (7.91) 4.02, 13.72 6/139 (4.32) 1.60, 9.16 7/139 (5.04) 2.05, 10.10 24/139 (17.27) 11.39, 24.59
Total 226/264 (85.61) 80.78, 89.61 24/264 (9.09) 5.91, 13.22 7/264 (2.65) 1.07, 5.39 7/264 (2.65) 1.07, 5.39 38/264 (14.39) 10.39, 19.22
Kenya
New 287/297 (96.63) 93.90, 98.37 4/297 (1.35) 0.37, 3.41 1/297(0.34) 0.01, 1.86 5/297 (1.68) 0.55, 3.88 10/297 (3.37) 1.63, 6.10
Follow-up 100/104 (96.15) 90.44, 98.94 1/104 (0.96) 0.02, 5.10 0/104 (0.00) 0.00, 3.48 3/104 (2.88) 0.60, 8.20 4/104 (3.85) 1.06, 9.56
Retreatment 23/31 (74.19) 55.39, 88.14 7/31 (22.58) 9.59, 41.10 0/31 (0.00) 0.00, 11.22 1/31 (3.23) 0.08, 16.70 8/31 (25.81) 11.86, 44.61
Unknown 1/2 (50.00) 1.26, 98.74 0/2 (0.00) 0.00, 84.19 0/2 (0.00) 0.00, 84.19 1/2 (50.00) 1.26, 98.74 1/2 (50.00) 1.26, 98.74
Total 411/434 (94.70) 92.15, 96.61 12/434 (2.76) 1.44, 4.78 1/434 (0.23) 0.01, 1.28 10/434 (2.30) 1.11, 4.20 23/434 (5.30) 3.39, 7.85
Uganda
New 90/107 (84.11) 75.78, 90.46 12/107 (11.21) 5.93, 18.77 3/107 (2.80) 0.58, 7.98 2/107 (1.87) 0.23, 6.59 17/107 (15.89) 9.54, 24.22
Follow-up 17/18 (94.44) 72.71, 99.86 0/18 (0.00) 0.00, 18.53 1/18 (5.56) 0.14, 27.29 0/18 (0.00) 0.00, 18.53 1/18 (5.56) 0.14, 27.29
Retreatment 0/1 (0.00) 0.00, 97.50 0/1 (0.00) 0.00, 97.50 0/1(0.00) 0.00, 97.50 1/1 (100.00) 2.50, 100.00 1/1 (100.00) 2.50, 100.00
Unknown 1/1 (100) 2.50, 100.00 0/1 (0.00) 0.00, 97.50 0/1(0.00) 0.00, 97.50 0/1 (0.00) 0.00, 97.50 0/1(0.00) 0.00, 97.50
Total 108/127 (85.04) 77.63, 90.75 12/127 (9.45) 4.98, 15.92 4/127 (3.15) 0.86, 7.87 3/127 (2.36) 0.49, 6.75 19/127 (14.96) 9.25, 22.37
Zambia
Unknown 37/45 (82.22) 67.95, 92.00 3/45 (6.67) 1.40, 18.27 4/45 (8.89) 2.48, 21.22 1/45 (2.22) 0.06, 11.77 8/45 (17.78) 8.00, 32.05
Total 37/45 (82.22) 67.95, 92.00 3/45 (6.67) 1.40, 18.27 4/45 (8.89) 2.48, 21.22 1/45 (2.22) 0.06, 11.77 8/45 (17.78) 8.00, 32.05
Overall
New 488/529 (92.25) 89.63, 94.38 29/529 (5.48) 3.70, 7.78 5/529 (0.95) 0.31, 2.19 7/529 (1.32) 0.53, 2.71 41/529 (7.75) 5.62, 10.37
Follow-up 117/122 (95.90) 90.69, 98.66 1/122 (0.82) 0.02, 4.48 1/122 (0.82) 0.02, 4.48 3/122 (2.46) 0.51, 7.02 5/122 (4.10) 1.34, 9.31
Retreatment 23/32 (71.88) 53.25, 86.25 7/32 (21.88) 9.28, 39.97 0/32 (0.00) 0.00, 10.89 2/32 (6.25) 0.77, 20.81 9/32 (28.13) 13.75, 46.75
Unknown 153/187 (81.82) 75.53, 87.07 14/187 (7.49) 4.15, 12.24 10/187 (5.35) 2.59, 9.61 9/187 (4.81) 2.22, 8.94 33/187 (17.65) 12.47, 23.88
Total 782/870 (89.89) 87.69, 91.81 51/870 (5.86) 4.40, 7.64 16/870 (1.84) 1.05, 2.97 21/870 (2.41) 1.50, 3.67 88/870 (10.11) 8.19, 12.31